This Article Full Text Full Text (PDF) All Versions of this Article: 36/2/e4    most recent 01.STR.0000151328.70519.e9v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Berger, C. Articles by Schwab, S. Search for Related Content PubMed PubMed Citation Articles by Berger, C. Articles by Schwab, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUTAMIC ACID HYDROCHLORIDE GLYCERIN LACTIC ACID Related Collections Acute Cerebral Infarction Brain Circulation and Metabolism Emergency treatment of Stroke Other Stroke Treatment - Medical

(Stroke. 2005;36:e4.)
© 2005 American Heart Association, Inc.

Short Communication

Neurochemical Monitoring of Glycerol Therapy in Patients With Ischemic Brain Edema

From the Departments of Neurology (C.B., S.S.) and Neurosurgery (O.W.S., K.L.K.), University of Heidelberg, Germany.

Correspondence to Dr Christian Berger, Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. E-mail christian_berger{at}med.uni-heidelberg.de

Background and Purpose— Osmotic agents such as glycerol are used to treat brain edema in stroke patients. We investigated the pharmacokinetics of glycerol in brain tissue by cerebral microdialysis.

Methods— Patients experiencing large middle cerebral artery infarction were included in this prospective study. The following variables were assessed before and every 10 minutes until 80 minutes after intravenous administration of 25 g of glycerol: intracranial pressure (ICP), serum osmolarity, and cerebral microdialysate concentrations of glycerol, glutamate, pyruvate, and lactate.

Results— During 16 ICP crises in 7 patients, cerebral glycerol concentrations (baseline 73.9±17.0 µmol/L) increased immediately after glycerol administration by up to 350%. Conversely, ICP (baseline 25±2.4 mm Hg) rapidly decreased by almost 50%. Both effects lasted for 70 minutes. Serum osmolarity (baseline 305±5.6 mOsm/L) was only briefly raised, whereas glutamate, lactate, and pyruvate remained unaffected.

Conclusion— Treatment of stroke patients with intravenous glycerol has only a brief effect on plasma osmolarity, but a more sustained effect on ICP, which is, however, accompanied by a rapid glycerol accumulation in brain tissue.

Key Words: brain edema • infarction • intracranial pressure • middle cerebral artery

This article has been cited by other articles:

				P. Georgiadis, H. Xu, C. Chua, F. Hu, L. Collins, C. Huynh, E. F. LaGamma, and P. Ballabh Characterization of Acute Brain Injuries and Neurobehavioral Profiles in a Rabbit Model of Germinal Matrix Hemorrhage Stroke, December 1, 2008; 39(12): 3378 - 3388. [Abstract] [Full Text] [PDF]